These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

134 related articles for article (PubMed ID: 4276108)

  • 21. [Complications in treatment with beta blockader Practolol (Eraldin)].
    Brinck HP; Aasved H; Jacobsen KB
    Tidsskr Nor Laegeforen; 1975 Aug; 95(24):1357-9, 1352. PubMed ID: 126503
    [No Abstract]   [Full Text] [Related]  

  • 22. Cutaneous and ocular reactions to practolol.
    Felix RH; Ive FA; Dahl MG
    Br Med J; 1974 Nov; 4(5940):321-4. PubMed ID: 4279720
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Aggravation of psoriasis and occurrence of psoriasiform cutaneous eruptions induced by practolol (Eraldin).
    Sondergaard J; Wadskov S; Jensen HA; Mikkelsen HI
    Acta Derm Venereol; 1976; 56(3):239-43. PubMed ID: 59510
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Fibrinous peritonitis and ocular reactions: a complication of practolol therapy (author's transl)].
    Kestens PJ; Muschart JM; Koerperich G; Aubry E
    Acta Gastroenterol Belg; 1977; 40(3-4):175-87. PubMed ID: 899618
    [No Abstract]   [Full Text] [Related]  

  • 25. [Ocular complications following practolol administration].
    Wolter-Czerwińska H; Filipowicz-Banachowa AF
    Klin Oczna; 1976; 46(10):1103-6. PubMed ID: 979060
    [No Abstract]   [Full Text] [Related]  

  • 26. [Conjunctivitis, stomatitis, glossitis, otitis and psoriasiform skin diseases during long-term treatment with practolol (Eraldin)].
    Byrn E; Reersted P
    Ugeskr Laeger; 1975 Apr; 137(18):1019-20. PubMed ID: 124970
    [No Abstract]   [Full Text] [Related]  

  • 27. Oculocutaneous reaction to oxprenolol.
    Holt PJ; Waddington E
    Br Med J; 1975 Jun; 2(5970):539-40. PubMed ID: 125135
    [No Abstract]   [Full Text] [Related]  

  • 28. Ocular disorders resulting from treatment with practolol (Eraldin) [proceedings].
    Cruysberg JR; Pinckers A
    Ophthalmologica; 1977; 175(1):39-40. PubMed ID: 904900
    [No Abstract]   [Full Text] [Related]  

  • 29. [Practolol (Eraldin)].
    van der Meer J
    Ned Tijdschr Geneeskd; 1975 Jun; 119(25):999-1000. PubMed ID: 49864
    [No Abstract]   [Full Text] [Related]  

  • 30. Letter: Ocular reactions to beta-blockers.
    Lyall JR
    Br Med J; 1975 Jun; 2(5973):747. PubMed ID: 237597
    [No Abstract]   [Full Text] [Related]  

  • 31. [Ocular toxicity of practolol: study of lacrimal proteins apropos of a case we were permitted to observe].
    Liotet S; N'Guyen H; Boissin JP
    Bull Soc Ophtalmol Fr; 1981 Feb; 81(2):201-4. PubMed ID: 7226389
    [No Abstract]   [Full Text] [Related]  

  • 32. Practolol and the nephrotic syndrome.
    Farr MJ; Wingate JP; Shaw JN
    Br Med J; 1975 Apr; 2(5962):68-9. PubMed ID: 1131550
    [No Abstract]   [Full Text] [Related]  

  • 33. Practolol and deafness.
    Jones RF; Hammond VT; Wright D; Ballantyne JC
    J Laryngol Otol; 1977 Nov; 91(11):963-72. PubMed ID: 145453
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Immunological changes and practolol.
    Amos HE; Brigden WD
    Lancet; 1976 Dec; 2(7998):1298. PubMed ID: 63765
    [No Abstract]   [Full Text] [Related]  

  • 35. The elimination of practolol by two human subjects.
    Dring LG; Gorchein A; Mahgoub AA; Smith RL
    Br J Clin Pharmacol; 1978 Mar; 5(3):262-5. PubMed ID: 148896
    [No Abstract]   [Full Text] [Related]  

  • 36. Editorial: side effects of practolol.
    Br Med J; 1975 Jun; 2(5971):577-8. PubMed ID: 124197
    [No Abstract]   [Full Text] [Related]  

  • 37. HL-A histocompatibility antigens and cutaneous reactions to practolol.
    Wadskov S; Sondergaard J; Svejgaard A; Mikkelsen HI; Jensen HA
    Acta Derm Venereol; 1976; 56(2):161-2. PubMed ID: 58528
    [No Abstract]   [Full Text] [Related]  

  • 38. [From The committee for the Registration of Adverse Effects. Adverse effects following Eraldin therapy].
    Lunde I; Borchgrevink CF
    Tidsskr Nor Laegeforen; 1975 Oct; 95(28):1609. PubMed ID: 1179394
    [No Abstract]   [Full Text] [Related]  

  • 39. A ranked presentation of the MHRA/CSM (Medicines & Health Care Regulatory Agency/Committee on Safety of Medicines) Drug Analysis Print (DAP) data on practolol.
    Mann RD
    Pharmacoepidemiol Drug Saf; 2005 Oct; 14(10):705-10. PubMed ID: 16088980
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Adverse reactions to practolol: some observations on the possible relevence to immune mechanisms.
    Dick HM; Wright P; Chapman CM; Zacharias FJ; Nicholls JT
    Allergy; 1978 Apr; 33(2):71-5. PubMed ID: 80139
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.